糖尿病人群中耐药革兰阴性菌血流感染的研究进展

doi:10.16138/j.1673-6087.2023.02.013

摘要/Abstract

中图分类号:

R587.1

高玉莲, 冯耘, 倪磊. 糖尿病人群中耐药革兰阴性菌血流感染的研究进展[J]. 内科理论与实践, 2023, 18(02): 124-127.

GAO Yulian, FENG Yun, NI Lei. Research progress of drug-resistant gram-negative bacteria bloodstream infection in diabetic population[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(02): 124-127.

参考文献 38

[1]	Hu FP. China Antimicrobial Surveillance Network, the results of bacterial resistance in 2021[DB/OL]. 2022. https://www.chinets.com/Document.
[2]	Babiker A, Clarke LG, Saul M, et al. Changing epidemiology and decreased mortality associated with carbapenem-resistant Gram-negative bacteria, 2000-2017[J]. Clin Infect Dis, 2021, 73(11): e4521-e4530. doi: 10.1093/cid/ciaa1464 URL
[3]	Nanditha A, Ma RC, Ramachandran A, et al. Diabetes in Asia and the Pacific: implications for the global epidemic[J]. Diabetes Care, 2016, 39(3): 472-485. doi: 10.2337/dc15-1536 pmid: 26908931
[4]	鲍强, 杨荣礼, 徐敏, 等. 糖尿病合并血流感染耐药性的相关性[J]. 临床与病理杂志, 2021, 41(5): 1064-1074.
[5]	Huang CH, Chiu CH, Chen IW, et al. Antimicrobial resistance and outcomes of community-onset bacterial bloodstream infections in patients with type 2 diabetes[J]. J Glob Antimicrob Resist, 2018, 15: 271-276. doi: 10.1016/j.jgar.2018.08.008 URL
[6]	Shaik S, Ranjan A, Tiwari SK, et al. Comparative genomic analysis of globally dominant ST131 clone with other epidemiologically successful extraintestinal pathogenic Escherichia coli (ExPEC) lineages[J]. MBio, 2017, 8(5): e01596-e01617.
[7]	Daga AP, Koga VL, Soncini JGM, et al. Escherichia coli bloodstream infections in patients at a university hospital[J]. Front Cell Infect Microbiol, 2019, 9: 191. doi: 10.3389/fcimb.2019.00191 URL
[8]	Isendahl J, Giske CG, Hammar U, et al. Temporal dynamics and risk factors for bloodstream infection with extended-spectrum β-lactamase-producing bacteria in previously-colonized individuals[J]. Clin Infect Dis, 2018, 68(4): 641-649. doi: 10.1093/cid/ciy539 URL
[9]	Tchesnokova V, Riddell K, Scholes D, et al. The uropathogenic Escherichia coli subclone sequence type 131-H30 is responsible for most antibiotic prescription errors at an urgent care clinic[J]. Clin Infect Dis, 2019, 68(5): 781-787. doi: 10.1093/cid/ciy523 pmid: 29961840
[10]	Harada S, Aoki K, Yamamoto S, et al. Clinical and molecular characteristics of Klebsiella pneumoniae isolates causing bloodstream infections in Japan[J]. J Clin Microbiol, 2019, 57(11): e01206-e01219.
[11]	Liao WC, Chung WS, Lo YC, et al. Changing epidemiology and prognosis of nosocomial bloodstream infection: a single-center retrospective study in Taiwan[J]. J Microbiol Immunol Infect, 2022, 55(6 Pt 2):1293-1300. doi: 10.1016/j.jmii.2021.09.015 URL
[12]	Cheng CY, Kung CT, Chen FC, et al. Impact of prior statin use on mortality in patients with type 2 diabetes mellitus and bloodstream infection[J]. J Int Med Res, 2019, 47(8): 3636-3647. doi: 10.1177/0300060519856137 URL
[13]	Leung CH, Liu CP. Diabetic status and the relationship of blood glucose to mortality in adults with carbapenem-resistant Acinetobacter baumannii complex bacteremia[J]. J Microbiol Immunol Infect, 2019, 52(4): 654-662. doi: 10.1016/j.jmii.2018.06.005 URL
[14]	Jung JS, Hamacher C, Gross B, et al. Evaluation of a semiquantitative matrix-assisted laser desorption ionization-time of flight mass spectrometry method for rapid antimicrobial susceptibility testing of positive blood cultures[J]. J Clin Microbiol, 2016, 54(11): 2820-2824. pmid: 27629893
[15]	Giacobbe DR, Giani T, Bassetti M, et al. Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications[J]. Clin Microbiol Infect, 2020, 26(6): 713-722. doi: 10.1016/j.cmi.2019.09.023 URL
[16]	Perez KK, Olsen RJ, Musick WL, et al. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia[J]. J Infect, 2014, 69(3): 216-225. doi: 10.1016/j.jinf.2014.05.005 pmid: 24841135
[17]	马丽平, 崔北辰, 关岚, 等. 2型糖尿病患者发生急性血流感染的预测指标分析[J]. 中国医刊, 2021, 56(9): 972-975.
[18]	Gao Q, Li Z, Mo X, et al. Combined procalcitonin and hemogram parameters contribute to early differential diagnosis of Gram-negative/Gram-positive bloodstream infections[J]. J Clin Lab Anal, 2021, 35(9):e23927.
[19]	耿男, 庞燕, 张静雯, 等. 血清降钙素原诊断成人革兰阴性菌血流感染价值的Meta分析[J]. 国际检验医学杂志, 2021, 42(23): 2822-2829.
[20]	侯钧, 张栋珉, 马瑜珊, 等. 糖尿病合并血流感染的病原学特征及预后危险因素分析[J]. 重庆医学, 2022, 51(15): 2622-2627.
[21]	Yo CH, Lee MT, Gi WT, et al. Prognostic determinants of community-acquired bloodstream infection in type 2 diabetic patients in ED[J]. Am J Emerg Med, 2014, 32(12):1450-1454. doi: 10.1016/j.ajem.2014.08.071 URL
[22]	Falcone M, Bassetti M, Tiseo G, et al. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae[J]. Crit Care, 2020, 24(1): 29. doi: 10.1186/s13054-020-2742-9
[23]	Hauck C, Cober E, Richter SS, et al. Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections[J]. Clin Microbiol Infect, 2016, 22(6): 513-519. doi: 10.1016/j.cmi.2016.01.023 URL
[24]	Zhang Y, Chen XL, Huang AW, et al. Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies[J]. Emerg Microbes Infect, 2016, 5(3): e27.
[25]	Sabino S, Soares S, Ramos F, et al. A cohort study of the impact of carbapenem-resistant enterobacteriaceae infections on mortality of patients presenting with sepsis[J]. MSphere, 2019, 4(2): e00052-e00119.
[26]	Hu F, Guo Y, Yang Y, et al. Resistance reported from China Antimicrobial Surveillance Network(CHINET) in 2018[J]. Eur J Clin Microbiol Infect Dis, 2019, 38(12):2275-2281. doi: 10.1007/s10096-019-03673-1
[27]	甄思思, 冯四洲. 头孢他啶-阿维巴坦在耐药菌感染中的临床应用研究进展[J]. 中国感染与化疗杂志, 2021, 21(6): 752-758. doi: 10.16718/j.1009-7708.2021.06.025
[28]	Giannella M, Bartoletti M, Gatti M, et al. Advances in the therapy of bacterial bloodstream infections[J]. Clin Microbiol Infect, 2020, 26(2): 158-167. doi: 10.1016/j.cmi.2019.11.001 URL
[29]	翟群超, 叶山东. 2型糖尿病合并血流感染研究进展[J]. 安徽医学, 2016, 37(9): 1176-1178.
[30]	Trevelin SC, Carlos D, Beretta M, et al. Diabetes mellitus and sepsis[J]. Shock, 2017, 47(3): 276-287. doi: 10.1097/SHK.0000000000000778 pmid: 27787406
[31]	Pearson-Stuttard J, Blundell S, Harris T, et al. Diabetes and infection: assessing the association with glycaemic control in population-based studies[J]. Lancet Diabetes Endocrinol, 2016, 4(2):148-158. doi: 10.1016/S2213-8587(15)00379-4 URL
[32]	Critchley JA, Carey IM, Harris T, et al. Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study[J]. Diabetes Care, 2018, 41(10): 2127-2135. doi: 10.2337/dc18-0287 pmid: 30104296
[33]	Sato J, Kanazawa A, Watada H. Type 2 diabetes and bacteremia[J]. Ann Nutr Metab, 2017, 71 Suppl 1: 17-22. doi: 10.1159/000479919 pmid: 28950280
[34]	Stoudt K, Chawla S. Don’t sugar coat it[J]. J Intensive Care Med, 2019, 34(11-12):889-896. doi: 10.1177/0885066618801748 pmid: 30309291
[35]	Abdelmalak BB, Lansang MC. Revisiting tight glycemic control in perioperative and critically ill patients: when one size may not fit all[J]. J Clin Anesth, 2013, 25(6):499-507. doi: 10.1016/j.jclinane.2012.09.006 pmid: 24008187
[36]	Yamada T, Shojima N, Noma H, et al. Glycemic control, mortality, and hypoglycemia in critically ill patients[J]. Intensive Care Med, 2017, 43(1):1-15. doi: 10.1007/s00134-016-4523-0 URL
[37]	American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020[J]. Diabetes Care, 2020, 43 Suppl 1:S14-S31.
[38]	Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016[J]. Intensive Care Med, 2017, 43(3): 304-377. doi: 10.1007/s00134-017-4683-6 pmid: 28101605

糖尿病人群中耐药革兰阴性菌血流感染的研究进展

Research progress of drug-resistant gram-negative bacteria bloodstream infection in diabetic population

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 38

相关文章 15

编辑推荐

Metrics

本文评价

[1]	张梦潇, 韦晓, 张少红, 陈国芳, 刘超. 生长分化因子15：减重治疗的新靶点[J]. 内科理论与实践, 2023, 18(02): 128-130.
[2]	中华医学会内分泌学分会. 老年与儿童青少年糖尿病人群新型冠状病毒感染临床应对指南[J]. 内科理论与实践, 2023, 18(01): 10-12.
[3]	张梦潇, 孙烁烁, 韦晓, 张少红, 陈国芳, 刘超. 生酮饮食诱导db/db小鼠肝脏脂肪沉积[J]. 内科理论与实践, 2023, 18(01): 56-63.
[4]	卜凡玉　郭晓峰　徐鹏　王进　薛明宇　潘筱云. 抗生素骨水泥联合其他综合干预措施治疗糖尿病足骨髓炎[J]. 组织工程与重建外科杂志, 2022, 18(4): 328-.
[5]	缪雅, 刘丽丽, 侯田志超, 严青华, 庞怡, 吴春晓, 程旻娜, 施燕, 黎衍云, 田景琰. 上海糖尿病前期人群恶性肿瘤发病风险分析[J]. 内科理论与实践, 2022, 17(06): 435-440.
[6]	阮铭, 侯田志超, 王海燕, 黎衍云, 周冰心, 包超慧, 秦洁洁, 王宇光, 方海, 朱伟嵘, 田景琰. 糖尿病前期“治未病”的几何深度学习与计算医学研究展望[J]. 内科理论与实践, 2022, 17(06): 475-481.
[7]	秦雪, 郭华, 张云云, 崔小川. C1q肿瘤坏死因子相关蛋白3与代谢相关疾病的研究进展[J]. 内科理论与实践, 2022, 17(06): 482-485.
[8]	许晴, 邵慧英, 陈帅, 全进伟, 周清芬, 王敏慧. 延续健康教育和指导对干预2型糖尿病患者冠状动脉斑块进展的影响[J]. 内科理论与实践, 2022, 17(04): 330-333.
[9]	高晶晶, 高艳虹. 早发2型糖尿病流行病学、临床特征及病因机制的研究进展[J]. 内科理论与实践, 2022, 17(04): 344-348.
[10]	孙洪平, 陈国芳, 刘超. 植物性饮食与2型糖尿病的研究进展[J]. 内科理论与实践, 2022, 17(04): 349-352.
[11]	中华医学会内分泌学分会. 新型冠状病毒肺炎疫情下糖尿病管理专家建议[J]. 诊断学理论与实践, 2022, 21(02): 136-138.
[12]	卞秀娟, 包志瑶, 陈虹, 承璐潇, 石宝平. 血流感染耐碳青霉烯类肺炎克雷伯菌患者的死亡危险因素分析[J]. 内科理论与实践, 2022, 17(01): 73-77.
[13]	李丽, 朱咏臻, 周敏, 钱嘉, 方丽莉. 2017年至2021年上海嘉定区某医院多重耐药菌分析[J]. 诊断学理论与实践, 2022, 21(01): 62-67.
[14]	陈煦阳, 顾卫琼. 胰岛素自身抗体临床检测应用局限及对策研究进展[J]. 诊断学理论与实践, 2022, 21(01): 95-98.
[15]	王永灵廖明娟李琰蒉纲. 阳和汤加减内服结合负压技术治疗糖尿病足[J]. 组织工程与重建外科杂志, 2021, 17(5): 426-.